Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
8.35
+0.46 (5.83%)
At close: Feb 26, 2026, 4:00 PM EST
8.35
0.00 (0.00%)
After-hours: Feb 26, 2026, 4:10 PM EST
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $217.13 million as of February 26, 2026. Its market cap has decreased by -54.40% in one year.
Market Cap
217.13M
Enterprise Value
74.39M
1-Year Change
-54.40%
Ranking
Category
Stock Price
$8.35
Market Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $217.13M, an increase of 30.75%. That is a compound annual growth rate of 12.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 205.17M | 9.43% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 205.98M |
| Kalaris Therapeutics | 205.17M |
| Galectin Therapeutics | 203.73M |
| Caribou Biosciences | 200.02M |
| Heron Therapeutics | 199.87M |
| Ovid Therapeutics | 196.58M |
| Eledon Pharmaceuticals | 194.41M |
| Sagimet Biosciences | 192.53M |